Connect With Us

Executive Team

360biolabs, a BioAgilytix Company

360biolabs - Melbourne headquarters
Scroll to page content

Leading the
Industry Together

360biolabs is recognised as Australia’s most diverse bioanalytical laboratory. It offers a comprehensive suite of pharmacokinetic and pharmacodynamic assays to support your Phase 1-3+ clinical trials.

Our advanced facilities in Melbourne and Brisbane are dedicated to leveraging state-of-the-art platforms and technologies for accurate and streamlined bioanalysis of innovative therapies.

Prioritising the importance of every sample, our rigorous attention to detail and adherence to strict quality standards (GLP, GCP, and ISO/IEC 17025) ensure unparalleled quality in bioanalysis.

BioAgilytix Global Team

360biolabs Executive Team

Davide Molho - CEO, Bioagilytix

Davide Molho

CEO, BioAgilytix

Davide Molho is the CEO of BioAgilytix, responsible for the company’s vision, growth strategy, and operational performance. He fosters innovation while addressing operational needs across its laboratories. Previously, he held senior roles at Charles River Laboratories, where he served as President and COO and was CEO at Evolution Research Group and Viroclinics Biosciences. Davide holds a degree in veterinary medicine from Milan University and began his career in R&D at Bracco.

Alistair Draffan's profile picture

Alistair Draffan PhD

President

Alistair Draffan co-founded 360biolabs in 2015, which was acquired by BioAgilytix in 2021, ensuring best practices in operational and quality management for studies in Australia. He has over 20 years of experience in the pharmaceutical and biotech industries, focusing on collaborative R&D and managing scientific operations. Previously, he was Director of Drug Discovery at Biota Pharmaceuticals, managing multidisciplinary research and advancing antiviral candidates into clinical trials. Alistair has a background in medicinal chemistry and a PhD in organic chemistry from the University of Nottingham.

Melinda Pryor's profile picture

Melinda Pryor PhD

Executive Vice President, Scientific Operations

Melinda Pryor co-founded 360biolabs in 2015, which was acquired by BioAgilytix in 2021. Melinda has a wealth of experience in the design and implementation of large multi-centre international clinical trials. Melinda has a PhD in virology and more than 25 years of experience in molecular virology and immunology and leads our high-performing clinical team. Melinda is focused on delivering regulatory-compliant data and providing expert clinical support to our clients.

Angela Luttick's profile picture

Angela Luttick

Executive Vice President, Commercial

Angela Luttick co-founded 360biolabs in 2015, which was acquired by BioAgilytix in 2021. Angela has more than 20 years of experience in the discovery, development, and commercialisation of novel drugs. Well-accustomed to leading multidisciplinary biology teams in the biotech and pharmaceutical industries and experienced in the generation of key discovery-stage biological data required for the preparation of IND packages used in filing numerous FDA submissions.

Melbourne city's CBD

Enabling future medicine together. Contact our team today to start your next early-phase clinical trial.

Connect With Us